Home >> Pharmaceuticals >> Food & Beverage >>

Partnerships, Licensing, Investments and M&A Deals and Trends for 2014 in Pharmaceuticals

Published: May-2015 | Format: PDF | GlobalData | Number of pages: 172 | Code: MRS - 18235

Partnerships, Licensing, Investments and M&A Deals and Trends for 2014 in Pharmaceuticals

Summary

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for 2014 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in 2014. The report portrays detailed comparative data on the number of deals and their value in the last five years, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalData’s proprietary in-house Pharmaceuticals deals database and primary and secondary research.

Scope

- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
- Analysis of partnership and licensing deals based on clinical stage of development of products.
- Summary of the pharmaceutical deals globally in the last five years.
- Information on the top deals happened in the pharmaceutical industry.
- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

Reasons to buy

- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing segments for investments in your industry.
- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
- Identify companies that are aggressively looking to raise capital in the market
- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
- Identify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 13
2 Pharmaceutical & Healthcare, Global, Deals Summary 18
2.1 Pharmaceutical & Healthcare, Global, Deals Analysis, 2014 18
2.1.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, 2014 by Quarter 20
2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, 2014 22
2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, 2014 23
2.4 Pharmaceuticals & Healthcare, Global, Top Deals, 2014 24
2.5 Pharmaceuticals & Healthcare, Top Deals, Global, Summaries, 2014 25
2.5.1 Actavis Acquires Allergan for USD70.5 Billion 25
2.5.2 Medtronic Acquires Covidien for USD49.9 Billion 26
2.5.3 Actavis Completes Acquisition of Forest Labs for USD28 Billion 27
2.5.4 Sigma-Aldrich Receives Antitrust Approval for its Acquisition by Merck for USD17 Billion 29
2.5.5 Novartis Acquires Cancer Drugs Business of GlaxoSmithKline 30
2.5.6 Bayer Acquires Consumer Healthcare Business of Merck for USD14.2 Billion 31
2.5.7 GlaxoSmithKline Acquires Consumer Healthcare Pharma Business of Novartis 32
2.5.8 Merck Acquires Cubist Pharma for USD9.5 Billion 33
2.5.9 McKesson Completes Acquisition Of Celesio For US$8.49 Billion 33
2.5.10 Roche Completes Tender Offer to Acquire InterMune for USD8.3 Billion 35
3 Pharmaceuticals & Healthcare, Global, Top Deal Makers, 2014 36
4 Pharmaceuticals & Healthcare, Global, Deal Summary, by Type 37
4.1 Pharmaceuticals & Healthcare, Global, M&A, 2014 37
4.1.1 Pharmaceuticals & Healthcare, Global, M&A, 2014 by Quarter 38
4.1.2 Top M&A Deals in 2014 39
4.1.3 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, 2014 40
4.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, 2014 41
4.2.1 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, 2014 by Quarter 42
4.2.2 Pharmaceuticals & Healthcare, Global, IPO Deals, 2014 43
4.2.3 Top IPOs in 2014 44
4.2.4 Pharmaceuticals & Healthcare, Global, Secondary Offerings Deals, 2014 45
4.2.5 Top Secondary Offerings in 2014 46
4.2.6 Pharmaceuticals & Healthcare, Global, PIPE Deals, 2014 47
4.2.7 Top PIPE Deals in 2014 48
4.2.8 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, 2014 48
4.3 Pharmaceuticals & Healthcare, Global, Debt Offering Deals, 2014 50
4.3.1 Pharmaceuticals & Healthcare, Global Debt Offerings, 2014 by Quarter 51
4.3.2 Pharmaceuticals & Healthcare, Global, Public Debt Offerings, 2014 52
4.3.3 Top Public Debt Offerings in 2014 53
4.3.4 Pharmaceuticals & Healthcare, Global, Private Debt Placements, 2014 54
4.3.5 Top Private Debt Placements in 2014 55
4.3.6 Pharmaceuticals & Healthcare, Global, Debt Offering Deals, by Therapy Area, 2014 55
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, 2014 57
4.4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, 2014 by Quarter 58
4.4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, 2014 60
4.4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Value (US$ m), 2014 61
4.4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), 2014 62
4.4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, 2014 63
4.4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), 2014 64
4.4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), 2014 65
4.4.8 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Deal Values, 2014 66
4.4.9 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, 2014 67
4.4.10 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payment, 2014 67
4.5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, 2014 68
4.5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, 2014 by Quarter 69
4.5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, 2014 70
4.5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Upfront & Milestone Payments and Deal Value (US$ m), 2014 71
4.5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), 2014 72
4.5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), 2014 73
4.5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), 2014 74
4.5.7 Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), 2014 75
4.5.8 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Values, 2014 76
4.5.9 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Upfront Payment, 2014 77
4.5.10 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Milestone Payment, 2014 78
4.6 Pharmaceuticals & Healthcare, Global, Private Equity Deals, 2014 79
4.6.1 Pharmaceuticals & Healthcare, Global, Private Equity Deals, 2014 by Quarter 80
4.6.2 Top Private Equity Deals in 2014 81
4.6.3 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, 2014 82
4.7 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, 2014 83
4.7.1 Pharmaceuticals & Healthcare, Global, Venture Financing Deals, 2014 by Quarter 84
4.7.2 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, 2014 85
4.7.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, 2014 86
4.7.4 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, 2014 87
4.7.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Last One Year 88
4.7.6 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, 2014 89
4.7.7 Top Venture Financing Deals in 2014 90
5 Pharmaceuticals & Healthcare, Global, Deal Summary, By Market 91
5.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, 2014 91
5.1.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, 2014 by Quarter 93
5.1.2 Oncology - Deals of the Year 94
5.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, 2014 98
5.2.1 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, 2014 by Quarter 100
5.2.2 Central Nervous System - Deals of the Year 101
5.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, 2014 104
5.3.1 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, 2014 by Quarter 106
5.3.2 Infectious Disease - Deals of the Year 107
5.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, 2014 111
5.4.1 Pharmaceuticals & Healthcare, Global, Immunology Deals, 2014 by Quarter 113
5.4.2 Immunology - Deals of the Year 114
5.5 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, 2014 117
5.5.1 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, 2014 by Quarter 119
5.5.2 Cardiovascular - Deals of the Year 120
5.6 Pharmaceuticals & Healthcare, Global, Metabolic Disorders Deals, 2014 123
5.6.1 Pharmaceuticals & Healthcare, Global, Metabolic Disorders Deals, 2014 by Quarter 125
5.6.2 Metabolic Disorders - Deals of the Year 126
5.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, 2014 130
5.7.1 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, 2014 by Quarter 132
5.7.2 Gastrointestinal - Deals of the Year 133
6 Pharmaceuticals & Healthcare, Deal Summary, By Geography 137
6.1 Pharmaceuticals & Healthcare, North America Region, Deals, 2014 137
6.1.1 Pharmaceuticals & Healthcare, North America Region, Deals, 2014 by Quarter 139
6.1.2 North America - Deals of the Year 140
6.2 Pharmaceuticals & Healthcare, European Region Deals, 2014 145
6.2.1 Pharmaceuticals & Healthcare, Europe, Deals, 2014 by Quarter 147
6.2.2 Europe - Deals of the Year 148
6.3 Pharmaceuticals & Healthcare, Asia-Pacific Region, Deals, 2014 152
6.3.1 Pharmaceuticals & Healthcare, Asia-Pacific Region Deals, 2014 by Quarter 154
6.3.2 Asia-Pacific - Deals of the Year 155
6.4 Pharmaceuticals & Healthcare, Rest of the World (ROW) Deals, 2014 158
6.4.1 Pharmaceuticals & Healthcare, Rest of the World Deals, 2014 by Quarter 160
6.4.2 Rest of the World - Deals of the Year 161
7 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 165
7.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, 2014 165
7.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, 2014 167
8 Further Information 169
8.1 Methodology 169
8.2 About GlobalData 170
8.3 Disclosure information 171
8.4 Disclaimer 171

1.1 List of Tables
Table 1: Pharmaceutical & Healthcare, Global, Deals Summary, Number of Deals and Deal Value (US$ m), 2010 - 2014 19
Table 2: Pharmaceuticals & Healthcare, Deals Summary, Global, Number of Deals and Deal Value (US$ m), Q1 2014-Q4 2014 21
Table 3: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), 2014 23
Table 4: Pharmaceuticals & Healthcare, Top Deals, Global, 2014 24
Table 5: Pharmaceuticals & Healthcare, Global, Top Deal Makers, Number of Deals and Deal Value (US$ m), 2014 36
Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), 2010 - 2014 38
Table 7: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 39
Table 8: Pharmaceuticals & Healthcare, Global, Top M&A Deals, 2014 39
Table 9: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, 2014 40
Table 10: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), 2010 - 2014 42
Table 11: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 43
Table 12: Pharmaceuticals & Healthcare, Global, IPO Deals, Deals Summary, Number of Deals and Deal Value (US$ m), 2010 - 2014 44
Table 13 Pharmaceuticals & Healthcare, Global, Top IPOs, 2014 44
Table 14: Pharmaceuticals & Healthcare, Global, Secondary Offerings, Deals Summary, Number of Deals and Deal Value (US$ m), 2010 - 2014 45
Table 15: Pharmaceuticals & Healthcare, Global, Top Secondary Offerings, 2014 46
Table 16: Pharmaceuticals & Healthcare, Global, PIPEs, Deals Summary, Number of Deals and Deal Value (US$ m), 2010 - 2014 47
Table 17: Pharmaceuticals & Healthcare, Global, Top PIPE Deals, 2014 48
Table 18: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$ m), 2014 49
Table 19: Pharmaceuticals & Healthcare, Global, Debt Offering, Deals Summary, Number of Deals and Deal Values (US$ m), 2010 - 2014 51
Table 20: Pharmaceuticals & Healthcare, Global, Debt Offering, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 52
Table 21: Pharmaceuticals & Healthcare, Global, Public Debt Offerings, Deals Summary, Number of Deals and Deal Value (US$ m), 2010 - 2014 53
Table 22: Pharmaceuticals & Healthcare, Global, Top Public Debt Offerings, 2014 53
Table 23: Pharmaceuticals & Healthcare, Global, Private Debt Placements, Deals Summary, Number of Deals and Deal Value (US$ m), 2010 - 2014 54
Table 24: Pharmaceuticals & Healthcare, Global, Top Private Debt Placements, 2014 55
Table 25: Pharmaceuticals & Healthcare, Global, Debt Offering Deals, Summary, Number of Deals and Deal Values (US$ m), 2014 56
Table 26: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), 2010 - 2014 58
Table 27: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 59
Table 28: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), 2014 60
Table 29: Pharmaceuticals & Healthcare, Partnership Deals, Upfront & Milestone Payment and Deal Values (US$ m), 2014 61
Table 30: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), 2014 62
Table 31: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, 2014 64
Table 32: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payment and Deal Values (US$ m), 2014 66
Table 33: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront & Milestone Payment and Deal Values (US$ m), 2014 66
Table 34: Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, 2014 67
Table 35: Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payment, 2014 67
Table 36: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), 2010 - 2014 68
Table 37: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 69
Table 38: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, Number of Deals and Deal Values (US$ m), 2014 70
Table 39: Pharmaceuticals & Healthcare, Licensing Agreements, Upfront & Milestone Payments and Deal Values (US$ m), 2014 71
Table 40: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, Upfront & Milestone Payments and Deal Values (US$ m), 2014 73
Table 41: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q4 2013 - Q4 2014 75
Table 42: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Upfront & Milestone Payments and Deal Values (US$ m), 2014 76
Table 43: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront & Milestone Payment and Deal Values (US$ m), 2014 76
Table 44: Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Upfront Payment, 2014 77
Table 45: Pharmaceutical & Healthcare, Global, Top Licensing Agreements, by Milestone Payment, 2014 78
Table 46: Pharmaceuticals & Healthcare, Global, Private Equity, Deals Summary, Number of Deals and Deal Values (US$ m), 2010 - 2014 80
Table 47: Pharmaceuticals & Healthcare, Global, Private Equity, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 81
Table 48: Pharmaceuticals & Healthcare, Global, Top Private Equity Deals, 2014 81
Table 49: Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Deals Summary, Number of Deals and Deal Values (US$ m), 2014 82
Table 50: Pharmaceuticals & Healthcare, Global, Venture Capital, Deals Summary, Number of Deals and Deal Values (US$ m), 2010 - 2014 84
Table 51: Pharmaceuticals & Healthcare, Global, Venture Capital, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 85
Table 52: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals and Deal Values (%), 2014 87
Table 53: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Therapy Area, Deals Summary, Number of Deals and Deal Values (US$ m), 2014 88
Table 54: Pharmaceutical & Healthcare, Global, Top VC Backed Companies, 2014 88
Table 55: Pharmaceuticals & Healthcare, Top Venture Financing Firms, Global, Number of Deals and Deal Value (US$ m), 2014 90
Table 56: Pharmaceuticals & Healthcare, Top Venture Financing Deals, Global, 2014 90
Table 57: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), 2010 - 2014 92
Table 58: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 94
Table 59: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), 2010 - 2014 99
Table 60: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 101
Table 61: Pharmaceuticals & Healthcare, Global, Infectious Disease, Deals Summary, Number of Deals and Deal Values (US$ m), 2010 - 2014 105
Table 62: Pharmaceuticals & Healthcare, Global, Infectious Disease, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 107
Table 63: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), 2010 - 2014 112
Table 64: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 114
Table 65: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), 2010 - 2014 118
Table 66: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 120
Table 67: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), 2010 - 2014 124
Table 68: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 126
Table 69: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), 2010 - 2014 131
Table 70: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 133
Table 71: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Value (US$ m), 2010 - 2014 138
Table 72: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Value (US$ m), Q1 2014-Q4 2014 140
Table 73: Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Value (US$ m), 2010 - 2014 146
Table 74: Pharmaceuticals & Healthcare, European Region Deals, Deals Summary, Global, Number of Deals and Deal Value (US$ m), Q1 2014-Q4 2014 148
Table 75: Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Value (US$ m), 2010 - 2014 153
Table 76: Pharmaceuticals & Healthcare, Asia-Pacific Region Deals, Deals Summary, Global, Number of Deals and Deal Value (US$ m), Q1 2014-Q4 2014 155
Table 77: Pharmaceuticals & Healthcare, Rest of the World Deals, Deals Summary, Number of Deals and Deal Value (US$ m), 2010 - 2014 159
Table 78: Pharmaceuticals & Healthcare, Rest of the World Deals, Deals Summary, Number of Deals and Deal Value (US$ m), Q1 2014-Q4 2014 161
Table 79: Pharmaceuticals & Healthcare, Global,, Top Financial Advisors, M&A, Number of Deals and Deal Value (US$ m), 2014 166
Table 80: Pharmaceuticals & Healthcare, Global Top Financial Advisors, Equity Offerings, Number of Deals and Deal Value (US$ m), 2014 168

1.2 List of Figures
Figure 1: Pharmaceutical & Healthcare, Global, Number of Deals and Deal Value (US$ m), 2010- 2014 18
Figure 2: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Value (US$ m), Q1 2014-Q4 2014 20
Figure 3: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), 2014 22
Figure 4: Pharmaceuticals & Healthcare, Global, Deal Values (%), 2014 23
Figure 5 Pharmaceuticals & Healthcare, Global, M&A, Number of Deals and Deal Values (US$ m), 2010 - 2014 37
Figure 6 Pharmaceuticals & Healthcare, Global, M&A, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 38
Figure 7: Pharmaceuticals & Healthcare, Global, M&As, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, 2014 40
Figure 8: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), 2010 - 2014 41
Figure 9: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 42
Figure 10: Pharmaceuticals & Healthcare, Global, IPO Deals, Number of Deals and Deal Value (US$ m), 2010 - 2014 43
Figure 11: Pharmaceuticals & Healthcare, Global, Secondary Offerings Deals, Number of Deals and Deal Value (US$ m), 2010 - 2014 45
Figure 12: Pharmaceuticals & Healthcare, Global, PIPE Deals, Number of Deals and Deal Value (US$ m), 2010 - 2014 47
Figure 13: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), 2014 48
Figure 14: Pharmaceuticals & Healthcare, Global, Debt Offering Deals, Number of Deals and Deal Values (US$ m), 2010 - 2014 50
Figure 15: Pharmaceuticals & Healthcare, Global, Debt Offering Deals, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 51
Figure 16: Pharmaceuticals & Healthcare, Global, Public Debt Offering Deals, Number of Deals and Deal Value (US$ m), 2010 - 2014 52
Figure 17: Pharmaceuticals & Healthcare, Global, Private Debt Placements, Number of Deals and Deal Value (US$ m), 2010 - 2014 54
Figure 18: Pharmaceuticals & Healthcare, Global, Debt Offering Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), 2014 55
Figure 19: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), 2010 - 2014 57
Figure 20: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 58
Figure 21: Pharmaceuticals & Healthcare, Global, Partnership Deals Break down (%), 2014 59
Figure 22: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), 2014 60
Figure 23: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront & Milestone Payments and Deal Values (US$ m), 2014 61
Figure 24: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), 2014 62
Figure 25: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, 2014 63
Figure 26: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, 2014 64
Figure 27: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), 2014 65
Figure 28: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), 2010 - 2014 68
Figure 29: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 69
Figure 30: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, Number of Deals and Deal Values (US$ m), 2014 70
Figure 31: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Upfront & Milestone Payments and Deal Values (US$ m), 2014 71
Figure 32: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), 2014 72
Figure 33: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Number Of Deals, 2014 73
Figure 34: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Deal Values (US$ m), 2014 74
Figure 35: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Phase, by Upfront & Milestone Payment and Deal Values (US$ m), 2014 75
Figure 36: Pharmaceuticals & Healthcare, Global, Private Equity, Number of Deals and Deal Values (US$ m), 2010 - 2014 79
Figure 37: Pharmaceuticals & Healthcare, Global, Private Equity, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 80
Figure 38: Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, 2014 82
Figure 39: Pharmaceuticals & Healthcare, Global, Venture Capital, Number of Deals and Deal Values (US$ m), 2010 - 2014 83
Figure 40: Pharmaceuticals & Healthcare, Global, Venture Capital, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 84
Figure 41: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals (%), 2014 85
Figure 42: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Deal Values (%), 2014 86
Figure 43: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, 2014 87
Figure 44: Pharmaceuticals & Healthcare, Top Venture Financing Firms, Global, Number of Deals and Deal Value (US$ m), 2014 89
Figure 45: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), 2010 - 2014 91
Figure 46: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 93
Figure 47: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), 2014, 2010 - 2014 98
Figure 48: Pharmaceuticals & Healthcare, Central Nervous System, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 100
Figure 49: Pharmaceuticals & Healthcare, Global, Infectious Disease, Number of Deals and Deal Value (US$ m), 2010 - 2014 104
Figure 50: Pharmaceuticals & Healthcare, Global, Infectious Disease, Number of Deals and Deal Value (US$ m), Q1 2014-Q4 2014 106
Figure 51: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), 2010 - 2014 111
Figure 52: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 113
Figure 53: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), 2010 - 2014 117
Figure 54: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 119
Figure 55: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Number of Deals and Deal Values (US$ m), 2010 - 2014 123
Figure 56: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 125
Figure 57: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), 2010 - 2014 130
Figure 58: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2014-Q4 2014 132
Figure 59: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Value (US$ m), 2010 - 2014 137
Figure 60: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Value (US$ m), Q1 2014-Q4 2014 139
Figure 61: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Value (US$ m), 2010 - 2014 145
Figure 62: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Value (US$ m), Q1 2014-Q4 2014 147
Figure 63: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Value (US$ m), 2010 - 2014 152
Figure 64: Pharmaceuticals & Healthcare, Asia-Pacific Region, Deals, Number of Deals and Deal Value (US$ m), Q1 2014-Q4 2014 154
Figure 65: Pharmaceuticals & Healthcare, Rest of the World Deals, Number of Deals and Deal Value (US$ m), 2010 - 2014 158
Figure 66: Pharmaceuticals & Healthcare, Rest of the World Deals, Number of Deals and Deal Value (US$ m), Q1 2014-Q4 2014 160
Figure 67: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, Number of Deals and Deal Value (US$ m), 2014 165
Figure 68: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Value (US$ m), 2014 167

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)3500 View Pricing